Runnegar M, Wei X, Berndt N, Hamm-Alvarez S F
University of Southern California Center for Liver Diseases, Los Angeles, USA.
Hepatology. 1997 Jul;26(1):176-85. doi: 10.1002/hep.510260123.
To understand the regulation of receptor-mediated endocytosis in hepatocytes, we have used two specific inhibitors of serine-threonine protein phosphatases (PP), microcystin (MCYST) and okadaic acid (OKA) as probes to alter protein phosphorylation in hepatocytes. We have then examined the impact of these changes on the specific binding and uptake of transferrin (Tf) in hepatocytes. The measurement of PP activity in hepatocyte lysates showed that OKA and MCYST shared a common inhibition of protein phosphatase 2A (PP2A). Our results showed that both OKA (250 nmol/L) and MCYST (500 nmol/L) significantly reduced Tf uptake at steady state (P < or = .05). The measurement of Tf internalization after 15 minutes in protein phosphatase inhibitor-pretreated cells revealed that the initial uptake was also significantly reduced. Binding studies showed that pretreatment with either of the phosphatase inhibitors did not result in significant changes in the K(d) for Tf binding to transferrin receptor (TfR). Additionally, no significant changes in the number of TfR in the plasma membrane were observed in phosphatase inhibitor-pretreated cells. The treatment of hepatocytes with nocodazole (NOC), which results in microtubule disassembly and inhibition of microtubule-based vesicle transport, caused comparable reductions in initial and steady state levels of transferrin accumulation. The changes in transferrin accumulation by both phosphatase inhibitors and nocodazole were accompanied by redistribution of the microtubule-anchored Golgi apparatus and lysosomal network from the perinuclear region to the cell periphery. Our data show that the regulation of Tf uptake by receptor-mediated endocytosis is mediated by PP2A and additionally may occur through regulation of microtubule-based vesicle transport.
为了解肝细胞中受体介导的内吞作用的调控机制,我们使用了两种丝氨酸 - 苏氨酸蛋白磷酸酶(PP)的特异性抑制剂,微囊藻毒素(MCYST)和冈田酸(OKA)作为探针来改变肝细胞中的蛋白质磷酸化。然后,我们研究了这些变化对肝细胞中转铁蛋白(Tf)特异性结合和摄取的影响。肝细胞裂解物中PP活性的测定表明,OKA和MCYST对蛋白磷酸酶2A(PP2A)具有共同的抑制作用。我们的结果表明,OKA(250 nmol/L)和MCYST(500 nmol/L)均显著降低了稳态下的Tf摄取(P≤0.05)。对蛋白磷酸酶抑制剂预处理细胞15分钟后的Tf内化测定显示,初始摄取也显著降低。结合研究表明,用任何一种磷酸酶抑制剂预处理均未导致Tf与转铁蛋白受体(TfR)结合的解离常数(K(d))发生显著变化。此外,在磷酸酶抑制剂预处理的细胞中,未观察到质膜上TfR数量的显著变化。用诺考达唑(NOC)处理肝细胞,其导致微管解聚并抑制基于微管的囊泡运输,引起转铁蛋白积累的初始水平和稳态水平出现类似程度的降低。磷酸酶抑制剂和诺考达唑引起的转铁蛋白积累变化均伴随着微管锚定的高尔基体和溶酶体网络从核周区域重新分布到细胞周边。我们的数据表明,受体介导的内吞作用对Tf摄取的调控由PP2A介导,此外可能通过对基于微管的囊泡运输的调控而发生。